bf/NASDAQ:AMGN_icon.jpeg

NASDAQ:AMGN

Amgen Inc.

  • Stock

$

USD

Last Close

233.10

23/03 20:11

Market Cap

127.1B

Beta: 0.63

Volume Today

2.176M

Avg: 2.665M

PE Ratio

19.86

PEG: 0.94

Dividend Yield

3.31%

Payout:64.92%

  • industry

    Drug Manufacturers / General
  • exchange

    NASDAQ Global Select
  • website

    www.amgen.com
  • ipo date

    May 01, 1987
  • full time employees

    25,200
  • currency

    USD

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory disease...Show More

Earnings

Earnings per Share (Estimate)

123452013-07-302015-07-302017-07-252019-07-302021-08-03

Revenue (Estimate)

1B2B3B4B5B6B7B2013-07-302015-07-302017-07-252019-07-302021-08-03

Revenue Breakdown

Segment Revenue
Product

24.3B

Product And Service

1.682B